» Articles » PMID: 29248611

A Vicious Interplay Between Genetic and Environmental Insults in the Etiology of Blood Cancers

Overview
Journal Exp Hematol
Specialty Hematology
Date 2017 Dec 18
PMID 29248611
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Over the years, the etiology of cancer has been attributed alternatively to genetic and environmental insults. According to the genetic hypothesis, cancer cells arise from the acquisition of mutations that dysregulate the intrinsic mechanisms controlling normal cell growth and survival. In contrast, the environmental hypothesis holds that cancer can be caused by multiple extrinsic challenges that alter normal tissue homeostasis, but may not necessarily involve mutations. It is, however, quite possible that these two mechanisms are not mutually exclusive. According to this third hypothesis, environmental challenges, by mechanisms still poorly understood, may act by imposing a selection pressure that confers a proliferative advantage on cells carrying specific driver mutations, leading to disease initiation. The authors of a brief report published in this journal (Exp Hematol. 2017;56:1-6) tested this third hypothesis experimentally and provide new evidence that chronic inflammation, by increasing tumor necrosis factor (TNF)-α, may positively select malignant hematopoietic stem cells (HSCs) carrying loss-of-function TET2 mutations that switch the TNF-α signaling responses to activate proliferation rather than inducing quiescence. Furthermore, these mutations skew hematopoietic differentiation toward the myelomonocytic lineage and the output of macrophages producing TNF-α constitutively, promoting further environment-independent expansion of the malignant HSCs. These findings support a model in which the formation of a malignant population is triggered by a vicious interplay between genetic (TET2 mutations) and environmental (inflammation) insults, suggesting the need for strategies that target both the malignant cells and their environment.

Citing Articles

Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in Mice.

Zingariello M, Verachi P, Gobbo F, Martelli F, Falchi M, Mazzarini M Biomolecules. 2022; 12(2).

PMID: 35204735 PMC: 8961549. DOI: 10.3390/biom12020234.


Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure.

Javier J, Hinge A, Bartram J, Xu J, Filippi M Haematologica. 2021; 107(6):1323-1334.

PMID: 34706493 PMC: 9152956. DOI: 10.3324/haematol.2020.273292.


Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: the 159th biomedical version of "it takes two to tango".

Zhan H, Kaushansky K Exp Hematol. 2018; 70:24-30.

PMID: 30593829 PMC: 6814245. DOI: 10.1016/j.exphem.2018.12.004.

References
1.
Kralovics R, Guan Y, Prchal J . Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol. 2002; 30(3):229-36. DOI: 10.1016/s0301-472x(01)00789-5. View

2.
Conboy I, Conboy M, Wagers A, Girma E, Weissman I, Rando T . Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005; 433(7027):760-4. DOI: 10.1038/nature03260. View

3.
Rossi D, Jamieson C, Weissman I . Stems cells and the pathways to aging and cancer. Cell. 2008; 132(4):681-96. DOI: 10.1016/j.cell.2008.01.036. View

4.
Seaman V, Jumaan A, Yanni E, Lewis B, Neyer J, Roda P . Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern Pennsylvania. Cancer Epidemiol Biomarkers Prev. 2009; 18(2):534-40. DOI: 10.1158/1055-9965.EPI-08-0922. View

5.
Jones A, Chase A, Silver R, Oscier D, Zoi K, Wang Y . JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet. 2009; 41(4):446-9. PMC: 4120192. DOI: 10.1038/ng.334. View